"Intrapericardial Approach" for Venous Outflow Reconstruction in Living-Donor Liver Transplantation for Budd-Chiari

Koichiro Hata1,2, Tetsuya Tajima1, Satoshi Ogiso1

  • 1Department of Surgery, Graduate School of Medicine Kyoto University Kyoto Japan.

Insights

The novel Intrapericardial Approach (IPA) for living-donor liver transplantation (LDLT) in Budd-Chiari Syndrome (BCS) significantly reduces recurrence and improves survival by reconstructing hepatic venous outflow using only healthy vessels.

Area of Science:

  • Hepatology
  • Transplant Surgery
  • Vascular Reconstruction

Background:

  • Living-donor liver transplantation (LDLT) for Budd-Chiari Syndrome (BCS) faces challenges in hepatic venous (HV)-inferior vena cava (IVC) reconstruction due to diseased native vessels.
  • BCS commonly involves the IVC in the Asia-Pacific region, necessitating innovative surgical techniques for HV-IVC reconstruction.

Purpose of the Study:

  • To introduce and evaluate the efficacy of the novel "intrapericardial approach" (IPA) for HV-IVC reconstruction in LDLT for BCS.
  • To compare the outcomes of IPA with conventional IVC-preserving techniques in BCS-LDLT patients.

Main Methods:

  • The study details the IPA technique for HV-outflow tract reconstruction in four typical LDLT scenarios for BCS, utilizing only healthy vascular tissues.
  • A retrospective comparison was made between 10 patients treated with IPA and 10 patients treated with conventional techniques (cavoplasty/patch-plasty) among 20 BCS-LDLT cases.

Main Results:

  • The IPA technique was consistently applicable across all BCS-LDLT scenarios.
  • IPA demonstrated significantly lower post-transplant BCS recurrence (p=0.04) compared to conventional methods.
  • IPA was associated with improved relapse-free (p=0.02) and overall recipient survival (p=0.03), achieving 100% graft and patient survival at 10 years.

Conclusions:

  • The Intrapericardial Approach (IPA) offers a novel and practical solution for challenging HV-IVC reconstruction in LDLT for BCS.
  • IPA is associated with reduced post-transplant BCS recurrence and favorable short- and long-term outcomes, including high graft and patient survival rates.

Related Concept Videos